相关实验视频
Updated: Sep 18, 2025
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.3K
TMAO和肠道微生物组:对心血管疾病-CKD-IBD轴的影响
Si Hyoung Kim1, Mi Young Yoon1,2,3, Sang Sun Yoon1,2,3
1Department of Microbiology and Immunology, Yonsei University College of Medicine, Seoul, Korea.
Annals of medicine
|June 23, 2025
概括
三甲基胺N氧化物 (TMAO) 是肠道微生物的代谢物,与心血管,脏和炎症性肠道疾病有关. 通过微生物组疗法减少TMAO可能为这些慢性疾病提供新的治疗策略.
科学领域:
- 微生物学 微生物学
- 代谢学 代谢学 代谢学
- 胃肠病学 胃肠病学
背景情况:
- 三甲基胺N-氧化物 (TMAO) 是一种由饮食中的胆和肉丁衍生的肠道微生物代谢物.
- 高水平的TMAO与心血管疾病 (CVD),慢性病 (CKD) 和炎症性肠病 (IBD) 有关.
- 对于TMAO在这些炎症和纤维状况的致病性作用的确切作用尚未完全理解.
研究的目的:
- 审查TMAO作为IBD-CKD-CVD疾病谱中的统一因素的潜在作用.
- 突出减少TMAO生产对于治疗慢性疾病的重要性.
- 探索针对微生物组的治疗方法,作为减少TMAO的战略.
主要方法:
- 对TMAO代谢及其与慢性疾病相关的现有研究进行文献综述.
- 对将TMAO与炎症,氧化应激和纤维化联系起来的拟议机制的分析.
- 评估目前和新兴的TMAO减少策略,重点关注微生物组干预措施.
主要成果:
- TMAO可能充当连接IBD,CKD和CVD的关键环节.
- 旨在限制TMAO生产的战略对于疾病管理很重要.
- 微生物组疗法是一个有希望的,创新的方法来控制TMAO水平.
结论:
- TMAO与一系列慢性疾病有关,包括IBD,CKD和CVD.
- 针对TMAO生产,特别是通过微生物组调制,提供了一个潜在的治疗途径.
- 对微生物组疗法的进一步研究可能会导致复杂的系统性疾病的新型治疗方法.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
401
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
401
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
01:17Chronic Bowel Disorders: Introduction
543
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
543
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
345
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
345
01:29Inflammatory Bowel Disease IV: Pharmacological Management
204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
204
01:17Gastritis-II: Pathophysiology
601
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
601